Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company's $6 billion forecast
Publishing timestamp: 2024-01-08 07:00:01
Summary
Moderna's Covid vaccine sales plunged by two-thirds in 2023 to $6.7 billion, meeting its forecast for the year. The drop in demand reflects a decrease in Covid cases and public concern about the virus. Moderna expects sales to further decline in 2024 but anticipates returning to sales growth in 2025 with the launch of new products.
Sentiment: MIXED
Tickers: MRNA,
Keywords: business, moderna inc, business news, health care industry, breaking news, biotechnology, biotech and pharmaceuticals, pharmaceuticals,